Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV.

Lloyd SB, Niven KP, Kiefel BR, Montefiori DC, Reynaldi A, Davenport MP, Kent SJ, Winnall WR.

Hum Vaccin Immunother. 2017 Nov 2;13(11):2726-2737. doi: 10.1080/21645515.2017.1368935. Epub 2017 Sep 26.

2.

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.

Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf1483. doi: 10.1126/scitranslmed.aaf1483.

PMID:
28794282
3.

High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo.

Lloyd SB, Lichtfuss M, Amarasena TH, Alcantara S, De Rose R, Tachedjian G, Alinejad-Rokny H, Venturi V, Davenport MP, Winnall WR, Kent SJ.

Virology. 2016 May;492:1-10. doi: 10.1016/j.virol.2016.02.008. Epub 2016 Feb 19.

4.

Simian immunodeficiency virus infection and immune responses in the pig-tailed macaque testis.

Winnall WR, Lloyd SB, De Rose R, Alcantara S, Amarasena TH, Hedger MP, Girling JE, Kent SJ.

J Leukoc Biol. 2015 Mar;97(3):599-609. doi: 10.1189/jlb.4A0914-438R. Epub 2015 Jan 20.

5.

The high cost of fidelity.

Lloyd SB, Kent SJ, Winnall WR.

AIDS Res Hum Retroviruses. 2014 Jan;30(1):8-16. doi: 10.1089/AID.2013.0153. Review.

Supplemental Content

Loading ...
Support Center